Busulfan-Dependent Hepatotoxicity of Antithymocyte Globulin Formulations During Conditioning for Hematopoietic Stem Cell Transplantation.
作者信息
van der Velden Walter J F M, de Weerd-de Jong Esther C, de Haan Anton F J, Blijlevens Nicole M A
机构信息
Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
出版信息
Biol Blood Marrow Transplant. 2018 Feb;24(2):410-412. doi: 10.1016/j.bbmt.2017.10.020. Epub 2017 Oct 16.
PMID:29051024
Abstract
摘要
相似文献
1
Busulfan-Dependent Hepatotoxicity of Antithymocyte Globulin Formulations During Conditioning for Hematopoietic Stem Cell Transplantation.造血干细胞移植预处理期间抗胸腺细胞球蛋白制剂的白消安依赖性肝毒性
Biol Blood Marrow Transplant. 2018 Feb;24(2):410-412. doi: 10.1016/j.bbmt.2017.10.020. Epub 2017 Oct 16.
2
Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.氟达拉滨、白消安和抗胸腺细胞球蛋白减低预处理后亲缘或非亲缘异基因干细胞移植的可比结局
Leuk Lymphoma. 2012 Jan;53(1):162-5. doi: 10.3109/10428194.2011.604754. Epub 2011 Aug 18.
3
Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.全身照射及环磷酰胺加抗胸腺细胞球蛋白方案耐受性良好，并且作为急性白血病T细胞充足的单倍体相合移植前的预处理方案，可促进稳定植入。
Biol Blood Marrow Transplant. 2014 Aug;20(8):1176-82. doi: 10.1016/j.bbmt.2014.04.012. Epub 2014 Apr 18.
4
Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?抗胸腺细胞球蛋白在白消安/氟达拉滨预处理方案用于匹配相关供者造血干细胞移植中是否有一席之地？
Korean J Intern Med. 2016 Jul;31(4):750-61. doi: 10.3904/kjim.2015.234. Epub 2016 Mar 28.
5
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.氟达拉滨、抗胸腺细胞球蛋白和极低剂量白消安用于淋巴细胞恶性肿瘤患者异基因造血干细胞移植前的低强度预处理。
Biol Blood Marrow Transplant. 2011 Nov;17(11):1698-703. doi: 10.1016/j.bbmt.2011.04.010. Epub 2011 May 3.
6
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).氟达拉滨、静脉用白消安和抗胸腺细胞球蛋白（FB2 方案）预处理的免疫状态和造血恢复对减低强度预处理异基因造血干细胞移植（allo-SCT）预后的影响。
Eur J Haematol. 2013 Mar;90(3):177-86. doi: 10.1111/ejh.12049. Epub 2013 Jan 27.
7
Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies.在采用白消安和氟达拉滨预处理方案的同胞全相合造血干细胞移植中，胸腺球蛋白在髓系恶性肿瘤中的作用。
Bone Marrow Transplant. 2018 Feb;53(2):207-212. doi: 10.1038/bmt.2017.240. Epub 2017 Oct 30.
8
9
Clinical Relevance of Apheretic Graft Composition in Patients With Acute Myeloblastic Leukemia Who Received a Busulfan-Fludarabine-Antithymocyte Globulin Conditioning Regimen for Allogeneic Transplant.接受白消安-氟达拉滨-抗胸腺细胞球蛋白预处理方案进行异基因移植的急性髓细胞白血病患者中，去除性移植物组成的临床相关性
Exp Clin Transplant. 2015 Oct;13(5):453-60. doi: 10.6002/ect.2014.0223. Epub 2015 Jun 15.
10
Effectiveness of fludarabine- and busulfan-based conditioning regimens in patients with acute myeloblastic leukemia: 8-year experience in a single center.氟达拉滨和白消安预处理方案治疗急性髓细胞白血病患者的疗效：单中心8年经验
Transplant Proc. 2015 May;47(4):1217-21. doi: 10.1016/j.transproceed.2014.10.059.
Zotero 插件